Munic S.A. (EPA:ALMUN)
France · Delayed Price · Currency is EUR 0.9100
-0.0300 (-3.19%)
Aug 1, 2025, 5:05 PM CET
Ligand Pharmaceuticals Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Operating Revenue | 11.58 | 17.18 | 24.13 | 22.48 | 9.62 | Upgrade |
Other Revenue | 0.02 | 0.02 | - | - | - | Upgrade |
| 11.6 | 17.19 | 24.13 | 22.48 | 9.62 | Upgrade | |
Revenue Growth (YoY) | -32.55% | -28.74% | 7.35% | 133.55% | -50.34% | Upgrade |
Cost of Revenue | 6.77 | 10.68 | 17.44 | 17.14 | 8.12 | Upgrade |
Gross Profit | 4.82 | 6.51 | 6.69 | 5.34 | 1.5 | Upgrade |
Selling, General & Admin | 5.36 | 6.06 | 5.54 | 5.62 | 5.12 | Upgrade |
Other Operating Expenses | -0.94 | 0.01 | 0.57 | 0.44 | 0.26 | Upgrade |
Operating Expenses | 6.97 | 8.68 | 7.72 | 6.52 | 5.79 | Upgrade |
Operating Income | -2.15 | -2.16 | -1.03 | -1.18 | -4.29 | Upgrade |
Interest Expense | -0.49 | -0.21 | -0.19 | -0.18 | -1.44 | Upgrade |
Currency Exchange Gain (Loss) | 0 | -0.3 | 0.13 | -0.18 | -0.11 | Upgrade |
Other Non Operating Income (Expenses) | 0 | 0.01 | 0 | 0.2 | -0.2 | Upgrade |
EBT Excluding Unusual Items | -2.63 | -2.65 | -1.1 | -1.34 | -6.04 | Upgrade |
Gain (Loss) on Sale of Investments | -0.03 | -0.11 | 0.08 | -0.12 | -0.02 | Upgrade |
Other Unusual Items | 0.6 | -0.03 | -0.01 | 0.04 | -0.37 | Upgrade |
Pretax Income | -2.05 | -2.8 | -1.03 | -1.41 | -6.43 | Upgrade |
Income Tax Expense | -0.93 | -1.01 | -1.04 | -1.18 | -0.77 | Upgrade |
Earnings From Continuing Operations | -1.12 | -1.79 | 0.01 | -0.23 | -5.65 | Upgrade |
Net Income to Company | -1.12 | -1.79 | 0.01 | -0.23 | -5.65 | Upgrade |
Net Income | -1.12 | -1.79 | 0.01 | -0.23 | -5.65 | Upgrade |
Net Income to Common | -1.12 | -1.79 | 0.01 | -0.23 | -5.65 | Upgrade |
Shares Outstanding (Basic) | 9 | 9 | 9 | 8 | 8 | Upgrade |
Shares Outstanding (Diluted) | 9 | 9 | 9 | 8 | 8 | Upgrade |
Shares Change (YoY) | 1.24% | - | 17.73% | -0.23% | 43.94% | Upgrade |
EPS (Basic) | -0.12 | -0.20 | 0.00 | -0.03 | -0.74 | Upgrade |
EPS (Diluted) | -0.12 | -0.20 | 0.00 | -0.03 | -0.74 | Upgrade |
Free Cash Flow | 2.74 | -1.69 | -3.19 | -5.05 | -6.89 | Upgrade |
Free Cash Flow Per Share | 0.30 | -0.19 | -0.36 | -0.66 | -0.90 | Upgrade |
Gross Margin | 41.58% | 37.89% | 27.73% | 23.74% | 15.58% | Upgrade |
Operating Margin | -18.50% | -12.57% | -4.29% | -5.25% | -44.56% | Upgrade |
Profit Margin | -9.65% | -10.42% | 0.06% | -1.02% | -58.73% | Upgrade |
Free Cash Flow Margin | 23.65% | -9.85% | -13.22% | -22.46% | -71.55% | Upgrade |
EBITDA | 0.4 | 0.44 | 0.58 | -0.72 | -3.88 | Upgrade |
EBITDA Margin | 3.48% | 2.58% | 2.39% | -3.20% | -40.30% | Upgrade |
D&A For EBITDA | 2.55 | 2.61 | 1.61 | 0.46 | 0.41 | Upgrade |
EBIT | -2.15 | -2.16 | -1.03 | -1.18 | -4.29 | Upgrade |
EBIT Margin | -18.50% | -12.57% | -4.29% | -5.25% | -44.56% | Upgrade |
Revenue as Reported | 13.09 | 17.74 | 25.74 | 22.37 | 10.37 | Upgrade |
Advertising Expenses | 0.02 | 0.02 | 0.03 | 0.02 | 0.03 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.